Clinical trials in Carmel, IN

13 recruiting studies have a site in or near Carmel, IN, Indiana.

Top conditions here

All conditions

Showing 13 of 13 studies

RecruitingPhase 3NCT06498635

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Sponsor: National Cancer Institute (NCI)

Avon, IN · Carmel, IN · Indianapolis, IN · +278 more sites

RecruitingPhase 3NCT07391774

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Sponsor: National Cancer Institute (NCI)

Avon, IN · Carmel, IN · Indianapolis, IN · +200 more sites

RecruitingPhase 3NCT07181109

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Sponsor: Alnylam Pharmaceuticals

Avon, IN · Carmel, IN · Evansville, IN · +270 more sites

RecruitingPhase 2NCT06656416

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Sponsor: Alto Neuroscience

Carmel, IN · West Lafayette, IN · +56 more sites

RecruitingNot applicableNCT05879913

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

Sponsor: Indiana University

Carmel, IN · Indianapolis, IN

RecruitingPhase 3NCT04692493

RA-PRO PRAGMATIC TRIAL

Sponsor: University of Alabama at Birmingham

Carmel, IN · +47 more sites

RecruitingPhase 3NCT05863195

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Sponsor: ECOG-ACRIN Cancer Research Group

Carmel, IN · Indianapolis, IN · +60 more sites

RecruitingPhase 2NCT05846789

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

Sponsor: Kathy Miller

Carmel, IN · Indianapolis, IN · +4 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Avon, IN · Carmel, IN · Crown Point, IN · +1223 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Avon, IN · Carmel, IN · Crown Point, IN · +825 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Avon, IN · Carmel, IN · Crown Point, IN · +809 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Avon, IN · Carmel, IN · Crown Point, IN · +952 more sites

RecruitingPhase 2NCT06134232

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Sponsor: Dendreon

Carmel, IN · Jeffersonville, IN · Merrillville, IN · +28 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.